PT UBC Medical Indonesia Tbk

Healthcare
Kawasan Industri Pulogadung, Jl. Rawa Gelam V, Blok L, No Kav 11-13, Kel. Jatinegara, Kec. Cakung, Jakarta Timur, Jakarta, 13930
62-21-3886-5110
www.ubcindonesia.com
137
2 (1,48%)
Data are delayed by at least 10 minutes

Summary

Open 137
Previous Close 135
Bid 0
Day high 138
Day Low 134
Value 0.4 B
Volume 27839
Frequency 958
Powered by RTI

Prediksi Pasar Saham

Berita Terkait

Industri | 29 Juli 2024
Perluas Portofolio Produk, UBC Medical Indonesia (LABS) Gandeng Bumame
UBC Medical Indonesia (LABS) gandeng Bumame luncurkan produk baru, yakni Hepatitis Viral Load Testing.
Investasi | 11 Juli 2024
Kembangkan Inovasi Blockchain, Tether Gandeng SeaSeed Network dari D3 Labs
Penandatanganan ini sangat penting.
Insight | 11 Juli 2024
Baru Melantai di Bursa, LABS Incar Laba Tumbuh 40%
PT UBC Medical Indonesia Tbk (LABS) resmi melantai di Bursa Efek Indonesia (BEI), Rabu (10/7).
Investasi | 10 Juli 2024
Melantai di BEI, UBC Medical Indonesia (LABS) Siapkan Strategi Saat Rupiah Melemah
Di perdagangan perdana hari ini, harga saham LABS mentok auto rejection atas (ARA) dengan kenaikan 34,31%.
Investasi | 10 Juli 2024
Pasca IPO, UBC Medical (LABS) Targetkan Pendapatan Rp 300 Miliar
PT UBC Medical Indonesia Tbk (LABS) menargetkan pendapatan Rp 300 miliar di tahun 2024.
Investasi | 10 Juli 2024
Melantai di Bursa, UBC Medical Indonesia (LABS) Oversubscribe 250 Kali
IPO UBC Medical Indonesia (LABS) berhasil kelebihan permintaan (oversubscribe) 250 kali
Investasi | 10 Juli 2024
Resmi Melantai di BEI Hari Ini, Saham UBC Medical Indonesia (LABS) Naik 34,31%
Saham perdana UBC Medical Indonesia (LABS) melonjak 34,31% ke Rp 137 per saham
Investasi | 21 Juni 2024
UBC Medical Indonesia (LABS) Mengincar Dana IPO Rp 73 Miliar, Ini Rencana Ekspansinya
UBC Medical Indonesia akan melantai di Bursa Efek Indonesia (BEI).
Insight | 17 Juni 2024
UBC Medical Indonesia (LABS) Mau IPO, Valuasi Harga Penawarannya Premium
Proforma PBV LABS pasca IPO sebesar 2,87 kali sampai 2,94 kali. 
English | 26 Maret 2024
US SEC Seeks US$2 Billion from Ripple Labs, Chief Legal Officer Says
The U.S. Securities and Exchange Commission is seeking fines and penalties totaling $2 billion in its case against Ripple Labs